Laden…
Substance Comparison
PCP stands out with markedly stronger dissociation. PCP leans slightly higher in addiction risk.
Despite belonging to different classes, these substances share receptor activity at NMDA and DAT, which may produce overlapping effects.
PCP has significantly higher dissociation
PCP has somewhat higher addiction risk
| PCP | Pramiracetam | |
|---|---|---|
| Class | Dissoziativa | Racetam |
| Risk Level | high | — |
| Mechanisms | NMDA-Antagonist, DAT-Inhibitor, Sigma-Agonist | Modulation der Acetylcholinaktivität |
| Receptors | NMDA, DAT, Sigma-1 | AMPA, NMDA, AChE, DAT |
| Effects | — | Verbesserte Konzentration und Fokus, Gesteigerte Gedächtnisleistung, Erhöhte mentale Klarheit, Verbesserte Lernfähigkeit, Neuroprotektive Wirkung |
| Evidence | — | unknown |
Pramiracetam wirkt als Modulator der Acetylcholinrezeptoren und kann die synaptische Plastizität im Gehirn erhöhen, was zu einer Verbesserung der kognitiven Funktionen führen kann.
No harm reduction data available
Safer-use data available on substance page
Evidence: not assessed · Sources: 2
Evidence: unknown · Sources: 2